Browsing Category

35568 posts

NYSE Content Advisory: Pre-Market update + Hinge Health, MNTN pop double digits in trading debuts

NEW YORK, May 23, 2025 /PRNewswire/ — The New York Stock Exchange…
WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development

WGC2025 | ENN Leverages "Intelligence + Low Carbon" to Pioneer a New Paradigm for Sustainable Energy Development

LANGFANG, China, May 23, 2025 /PRNewswire/ — From May 19 to 23,…
Enterprises from 39 Countries Join WCIFIT, with Thailand, Hong Kong, and Sichuan in the Spotlight

Enterprises from 39 Countries Join WCIFIT, with Thailand, Hong Kong, and Sichuan in the Spotlight

CHONGQING, China, May 23, 2025 /PRNewswire/ — A news report from iChongqing: Over…

UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study

SHANGHAI, May 23, 2025 /PRNewswire/ — Shanghai UniXell Biotechnology Co., Ltd. (UniXell…
HK Tech 300 Expo showcases hundreds of CityUHK incubated start-up innovations and achievements

HK Tech 300 Expo showcases hundreds of CityUHK incubated start-up innovations and achievements

HONG KONG, May 23, 2025 /PRNewswire/ — City University of Hong Kong (CityUHK)…

China Matters' Feature: Bridging Cultures at China-CEEC Expo: Central and Eastern European Voices in Ningbo

NINGBO, China, May 23, 2025 /PRNewswire/ — As the 2025 China-Central and Eastern…

Eason Technology Limited Receives Notification from NYSE Regarding Delayed Form 20-F Filing

HONG KONG, May 23, 2025 /PRNewswire/ — Eason Technology Limited ("Eason Technology" or…

Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting

Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the…